Purchase Order HHSN272201700937P

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Miltenyi Biotec, Inc. on September 13, 2018 for Illumina cell isolation and labelling kits with a ceiling value of $15,424.25.</p> <p>Performance is located in Auburn, California. The order carries a firm fixed-price structure with an ultimate completion date of October 31, 2018. No set-aside applies to this acquisition.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Miltenyi Biotec, Inc. for $21,688.50 on August 14, 2019, for a GentleMACS Octo Dissociator. Performance of manufacture and delivery occurs in Auburn, California. The order is firm fixed-price with an ultimate completion date of October 25, 2019. No set-aside applies.</p>

The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,950 firm-fixed-price purchase order to Miltenyi Biotec, Inc. for maintenance services. The order was placed on December 5, 2014 with a completion date of December 14, 2015. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to government agencies. This order is not associated with a set-aside program. Additionally, Miltenyi Biotec holds a...

This $6,929.75 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized instruments, reagents, and services for biomedical research and cell therapy development. The contract does not have a set-aside designation. Miltenyi Biotec is delivering a range of products and services to support NIAID's research programs, particularly in areas such as cancer,...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Miltenyi Biotec, Inc. for an AUTOMACS PRO Cell Separator valued at $34,950.00 on September 24, 2018. The order is firm fixed price with no set-aside. Place of performance is Bethesda, Maryland. Ultimate completion is scheduled for December 28, 2018. The solicitation was posted August 13, 2018, with a due date of August 22, 2018.</p>

This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The $51,351.50 Firm Fixed Price contract is for the supply of CD4 and CD8 microbeads and cell isolation kits. The award was not made under any set-aside program. The contract is likely part of a larger indefinite delivery contract (IDC) that Miltenyi Biotec holds with the NIH Clinical Center, valued at $2.3...

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $10,594.50 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The contract requires Miltenyi Biotec to deliver various cell...

The U.S. National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), awarded a firm fixed price purchase order worth $9,408.00 to Miltenyi Biotec, Inc., a global biotechnology company. The contract is for the delivery of four quarters' worth of premium service for an Automacs Classic cell separation instrument, at a unit price of $1,020.00 per quarter. This award supports NIAID's acquisition of specialized laboratory equipment and...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The $14,577 firm-fixed-price purchase order is for the supply of microbeads and columns for the MACS cell separation system, which is used to support biomedical research and cell therapy development programs at the NIH Clinical Center. This award is part of a larger indefinite...

The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,356 firm-fixed-price purchase order contract to Miltenyi Biotec, Inc., a global biotechnology company, for the delivery of isolation kits. This award is not associated with a set-aside program. Miltenyi Biotec provides specialized instruments, reagents, and services to support biomedical research and cell therapy development. Through this contract, the company will supply the NIAID with the necessary products for...